"Read the amended year end report filed by IPCI. With IPCI's consent, PAR has filed its own ANDA for focalin using other technology. This was only a gap move by PAR. Very bad business decision by IPCI. Also seems fraudulent that they have withheld this info until now."
I have no idea if true, but if it is, we have our answer as to what's going on.